Construction of STK11 Gene Fusion Plasmid and Its Effect on Migration of Lung Cancer Cells
-
摘要: 目的 构建表达STK11（serine/threonine kinase 11，STK11）基因和报告基因EGFP融合蛋白的重组质粒，并转染肺癌A549和H460细胞株，检测其对肺癌细胞迁移能力的影响。方法 构建重组质粒pEGFP-STK11，双酶切和测序进行鉴定。重组质粒转染A549和H460细胞株，荧光显微镜观察EGFP蛋白表达情况，Western blot检测STK11蛋白表达情况，划痕实验检测其对肺癌细胞迁移能力的影响。结果 酶切和测序结果表明pEGFP-STK11重组质粒构建成功；在转染A549和H460细胞后24h观察到绿色荧光最强；Western blot结果显示STK11蛋白在转染后24 h条带最深；划痕实验显示，转染组细胞迁移距离小于0.9%氯化钠溶液对照组（P<0.05）。结论 成功构建STK11基因重组质粒，并能转染A549和H460细胞，转染后对肺癌细胞迁移能力起一定抑制作用。Abstract: Objective To construct eukaryotic expression plasmids containing enhanced green fluorescent protein(EGFP) gene and serine/threonine kinase 11(STKK11) gene, and to explore its effect on migration of A549 and H460 cells. Methods Fusion plasmid of pEGFP-STK11 was constructed and identified by double restriction enzyme digestion and gene sequencing. The resultant plasmid was transfected into A549 and H460 cells respectively. The expression of EGFP and STK11 were observed by fluorescence microscopy and Western blot analysis. The cell migration ability was tested by Wound-healing assay. Results Enzyme digestion and DNA sequence analysis showed the recombinant vector of pEGFP-STK11 was constructed successfully. Fluorescence microscopy and Western blot analysis indicated STK11 gene was overexpressed in A549 and H460 cells after transfection, and reached the peak after 24 h. Wound-healing assay revealed cell migration distance of STK11 gene transfected group was significant less than that of control group (P<0.05). Conclusion STK11 gene fusion plasmid is constructed and transfected into lung cancer cell lines A549 and H460 successfully. Cells migration is inhibited to some extent after transfection.
-
Key words:
- Serine/threonine kinase 11(STK11) /
- Cells migration /
- A549 /
- H460
-
-
[1] van Lier MG, Wagner A, Mathus-Vliegen EM, et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations[J]. Am J Gastroenterol, 20 10,105(6): 1258-64. [2] Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome[J]. Nature, 19 98,391(6663):184-7. [3] Alessi DR, Sakamoto K, Bayascas JR. Lkb1-dependent signaling pathways[J]. Annu Rev Biochem, 2006,75:137-63. [4] Zhong D, Guo L, de Aguirre I, et al. Lkb1 mutation in large cell carcinoma of the lung[J]. Lung Cancer, 2006,53(3):285-94. [5] Sun LL, Zhong DS, Wu S, et al. Establishment and gene expression profiling of LKB1 stable knockdown lung cancer cell line[J]. Chin Med J (Engl), 2011,124(13):2028-32. [6] Lützner N, De-Castro Arce J, R?sl F. Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors[J]. PLoS One, 2012,7(3):e32590. [7] Gao Y, Xiao Q, Ma H, et al. LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling[J]. Proc Natl Acad Sci U S A, 2010, 107(44):18892-7. [8] Matsumoto S, Iwakawa R, Takahashi K, et al. Prevalence and specificity of LKB1 genetic alterations in lung cancers[J]. Oncogene, 2007, 26(40): 5911-8.
计量
- 文章访问数: 1502
- HTML全文浏览量: 426
- PDF下载量: 622
下载:
